|
|
|
| home > pmps > autumn 2003 > knowledge sharing in the clinical trials industry - annex 13 |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Let us start with the core functions provided by BlisTech UK.
BlisTech Clinical Trial Packaging Ltd's primary function is to provide a comprehensive clinical trial packaging service, providing primary and secondary packaging in a variety of presentations. BlisTech also provide storage, distribution and have two qualified persons (QPs) available for batch release under 75/319/EEC (2001/183/EEC). We also package and provide QP release for commercial products.
In our recent interview with Joseph Saccamono (PMPS Spring 2003) we talked about the aspect of technical knowledge sharing. How has that changed the demands of the European pharmaceutical companies?
Annex 13 has been the classic case where technical knowledge sharing has been crucial. The pharma business has had to wake up to the new GMP requirements to ensure they will be able to initiate and/or continue their clinical trials in May 2004. BlisTech has been sharing information in preparation for QP certification of batches for IMPs in 2004 with new and existing clients, as and when necessary. BlisTech have also employed two QPs to ensure their clients' needs will be met and will be applying for the new IMP Licence when the application forms are released by the MHRA.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Drive for generics sees Korea increasingly attractive to international pharma
Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical
multinationals, Korea is on course to become a global biotech and
pharmaceutical hub by 2025, driven by the surge of international
partnerships, biosimilars, an expansion in the export of finished
formulations and a robust generics market.
More info >> |
|
 |
White Papers |
 |
|
Keeping Abreast of the Competitive Environment in Clinical Development
Thomson Reuters
Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >> |
|
 |
Industry Events |
 |
CPhI & P-MEC India
26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India
As
the pharma
industry looks increasingly towards India forhigh quality, low cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer.
At
CPhI & P-MEC India, you will meet the movers and shakers from India’s
pharma machinery, technology and ingredients industries, giving you a
competitive advantage that will help grow your business.
More info >> |
|
|
